Literature DB >> 23318227

Subthalamic nucleus: a key structure for emotional component synchronization in humans.

Julie Péron1, Sascha Frühholz, Marc Vérin, Didier Grandjean.   

Abstract

Affective neuroscience is concerned with identifying the neural bases of emotion. For historical and methodological reasons, models describing the brain architecture that supports emotional processes in humans have tended to neglect the basal ganglia, focusing instead on cortical and amygdalar mechanisms. Now, however, deep brain stimulation (DBS) of the subthalamic nucleus (STN), a neurosurgical treatment for Parkinson's disease and obsessive-compulsive disorder, is helping researchers explore the possible functional role of this particular basal ganglion in emotional processes. After reviewing studies that have used DBS in this way, we propose a model in which the STN plays a crucial role in producing temporally organized neural co-activation patterns at the cortical and subcortical levels that are essential for generating emotions and related feelings.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23318227     DOI: 10.1016/j.neubiorev.2013.01.001

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  36 in total

1.  Structural and functional connectivity of the subthalamic nucleus during vocal emotion decoding.

Authors:  Julie Péron; Sascha Frühholz; Leonardo Ceravolo; Didier Grandjean
Journal:  Soc Cogn Affect Neurosci       Date:  2015-09-23       Impact factor: 3.436

Review 2.  Basal ganglia circuit loops, dopamine and motivation: A review and enquiry.

Authors:  Satoshi Ikemoto; Chen Yang; Aaron Tan
Journal:  Behav Brain Res       Date:  2015-04-20       Impact factor: 3.332

3.  Modification of spectral features by nonhuman primates.

Authors:  Daniel J Weiss; Cara F Hotchkin; Susan E Parks
Journal:  Behav Brain Sci       Date:  2014-12       Impact factor: 12.579

Review 4.  Effects of Subthalamic Nucleus Deep Brain Stimulation on Facial Emotion Recognition in Parkinson's Disease: A Critical Literature Review.

Authors:  S Kalampokini; E Lyros; P Lochner; K Fassbender; M M Unger
Journal:  Behav Neurol       Date:  2020-07-17       Impact factor: 3.342

5.  Targeting the subthalamic nucleus in a preclinical model of alcohol use disorder.

Authors:  Yann Pelloux; Christelle Baunez
Journal:  Psychopharmacology (Berl)       Date:  2017-04-11       Impact factor: 4.530

6.  Talking in Fury: The Cortico-Subcortical Network Underlying Angry Vocalizations.

Authors:  Sascha Frühholz; Hannah S Klaas; Sona Patel; Didier Grandjean
Journal:  Cereb Cortex       Date:  2014-04-15       Impact factor: 5.357

7.  Distinct populations of neurons respond to emotional valence and arousal in the human subthalamic nucleus.

Authors:  Tomáš Sieger; Tereza Serranová; Filip Růžička; Pavel Vostatek; Jiří Wild; Daniela Štastná; Cecilia Bonnet; Daniel Novák; Evžen Růžička; Dušan Urgošík; Robert Jech
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

8.  Subthalamic nucleus involvement in executive functions with increased cognitive load: a subthalamic nucleus and anterior cingulate cortex depth recording study.

Authors:  Stefania Rusnáková Aulická; Pavel Jurák; Jan Chládek; Pavel Daniel; Josef Halámek; Marek Baláž; Martina Bočková; Jan Chrastina; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2014-03-23       Impact factor: 3.575

Review 9.  Deconstructing arousal into wakeful, autonomic and affective varieties.

Authors:  Ajay B Satpute; Philip A Kragel; Lisa Feldman Barrett; Tor D Wager; Marta Bianciardi
Journal:  Neurosci Lett       Date:  2018-01-31       Impact factor: 3.046

10.  Sensory contribution to vocal emotion deficit in Parkinson's disease after subthalamic stimulation.

Authors:  Julie Péron; Sezen Cekic; Claire Haegelen; Paul Sauleau; Sona Patel; Dominique Drapier; Marc Vérin; Didier Grandjean
Journal:  Cortex       Date:  2014-09-16       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.